MeSH term
Frequency | Condition_Probility | Female | 13 | 0.0 |
Humans | 36 | 0.0 |
In Situ Hybridization, Fluorescence | 7 | 0.0 |
Nucleic Acid Hybridization/methods | 2 | 2.0 |
Prognosis | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Animals | 4 | 0.0 |
Base Sequence | 3 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
English Abstract | 4 | 0.0 |
Karyotyping | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 8 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 11 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Gene Amplification | 6 | 0.0 |
Gene Expression Profiling | 5 | 0.0 |
*In Situ Hybridization, Fluorescence | 2 | 1.0 |
*Oligonucleotide Array Sequence Analysis | 6 | 3.0 |
DNA Topoisomerases, Type II, Eukaryotic/genetics | 3 | 75.0 |
Multigene Family | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Chromosomes, Human, Pair 17/*genetics | 2 | 1.0 |
Gene Dosage | 4 | 1.0 |
Breast Neoplasms/*genetics/pathology | 5 | 2.0 |
Cell Proliferation | 2 | 1.0 |
Comparative Study | 8 | 0.0 |
Down-Regulation | 2 | 0.0 |
Up-Regulation | 4 | 0.0 |
Adolescent | 3 | 0.0 |
Adult | 8 | 0.0 |
Gene Expression Regulation, Neoplastic/*genetics | 3 | 1.0 |
Male | 10 | 0.0 |
Middle Aged | 7 | 0.0 |
Nerve Sheath Tumors/*genetics | 2 | 20.0 |
RNA, Messenger/genetics | 2 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Antimetabolites, Antineoplastic/*pharmacology | 2 | 2.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Fluorouracil/*pharmacology | 2 | 5.0 |
Forecasting | 2 | 0.0 |
*Gene Expression Profiling | 4 | 0.0 |
*Models, Theoretical | 2 | 3.0 |
Predictive Value of Tests | 4 | 0.0 |
Regression Analysis | 2 | 0.0 |
Stomach Neoplasms/*drug therapy/*genetics | 2 | 100.0 |
*DNA Topoisomerases, Type II, Eukaryotic | 3 | 15.0 |
Mice | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
DNA Topoisomerases, Type II/*genetics | 3 | 23.0 |
*Gene Amplification | 4 | 1.0 |
*Gene Deletion | 2 | 0.0 |
Isoenzymes/*genetics | 2 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Aged | 4 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Genes, erbB-2/*genetics | 4 | 10.0 |
Chromosome Deletion | 2 | 0.0 |
Chromosomes, Human, Pair 17/genetics | 3 | 1.0 |
DNA Topoisomerases, Type II, Eukaryotic/*genetics | 7 | 87.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Gene Amplification/genetics | 2 | 3.0 |
*Gene Dosage | 3 | 3.0 |
Models, Genetic | 2 | 0.0 |
Receptor, erbB-2/*genetics | 2 | 5.0 |
Reproducibility of Results | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Adenocarcinoma/*genetics | 3 | 2.0 |
Lung Neoplasms/*genetics | 2 | 0.0 |
Antigens, Neoplasm/*genetics | 2 | 3.0 |
Reference Values | 2 | 0.0 |
